In this article, we explore for the first time the alterations observed in brain volume, glucose metabolism and brain metabolites through in vivo MRI, FDG-PET and 1H-MRS ex vivo studies, in both Epm2a−/− and Epm2b−/− mouse models of Lafora disease. This evidence concerns the gene EPM2A and Lafora disease.